Coburn M C, Carney W I
Department of Surgery, Rhode Island Hospital, Providence.
J Vasc Surg. 1994 Dec;20(6):896-902; discussion 903-4. doi: 10.1016/0741-5214(94)90226-7.
The aim of this study was to compare patency and complication rates between basilic vein and polytetrafluoroethylene (PTFE) for brachial arteriovenous fistulas (AVF) for long-term hemodialysis.
All basilic vein and PTFE brachial AVF constructed between March 1988 and April 1993 were retrospectively reviewed. After construction of life-tables, log-rank testing was used to compare the primary patency rate of basilic vein AVF (n = 59) with the primary and secondary patency rates of PTFE AVF (n = 47). Complication rates were calculated for each type of fistula and compared by use of chi-squared testing.
The primary patency rate for basilic vein AVF (90%) was superior to that of PTFE AVF (70%) at 1 year (p < 0.01), and at 2 years (86% vs 49%, p < 0.001). Complications occurred two and a half times more frequently in the PTFE group than in the basilic vein group (p < 0.05).
Basilic vein AVF provided superior patency rates and lower complication rates compared with PTFE AVF. Prospective randomized trials comparing the two fistula types is required to firmly establish the basilic vein AVF as the alternative access procedure of choice after a failed or unconstructable radiocephalic fistula.
本研究旨在比较在长期血液透析中,肱动脉动静脉内瘘(AVF)使用贵要静脉和聚四氟乙烯(PTFE)时的通畅率和并发症发生率。
回顾性分析1988年3月至1993年4月间构建的所有贵要静脉和PTFE肱动脉AVF。构建生命表后,采用对数秩检验比较贵要静脉AVF(n = 59)的初始通畅率与PTFE AVF(n = 47)的初始和次级通畅率。计算每种类型内瘘的并发症发生率,并通过卡方检验进行比较。
贵要静脉AVF在1年时的初始通畅率(90%)高于PTFE AVF(70%)(p < 0.01),在2年时也是如此(86%对49%,p < 0.001)。PTFE组并发症的发生频率是贵要静脉组的2.5倍(p < 0.05)。
与PTFE AVF相比,贵要静脉AVF具有更高的通畅率和更低的并发症发生率。需要进行前瞻性随机试验来比较这两种类型的内瘘,以确定在头静脉桡动脉内瘘失败或无法构建后,贵要静脉AVF作为首选替代通路的地位。